Suzetrigine, approved in 2025 2 for moderate to severe acute pain, is poised to change the acute pain management paradigm. Approval was based on 2 Phase 3 clinical trials evaluating drug efficacy vs ...

Twenty-five years after the World Trade Center attacks, cancer has become the defining health problem among survivors who breathed the toxic dust. The number wh ...

SAMA and SABA + SAMA use associated with increased risk for heart failure, arrhythmia, and mortality versus no use ...

Linear dose-response relationships seen for all associations; most were partially mediated by shorter sleep duration ...

(HealthDay News) — From 2019 to 2026, there was an increase in glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescribing for children aged 8 to 11 years without diabetes but with obesity, ...

Atypical anorexia presents without low body weight, leading clinicians to frequently overlook the disorder and miss critical ...

Experts outline strategies for primary care providers to differentiate between excessive video game use and gaming disorder ...

FDA approves updated 2026-2027 COVID-19 vaccine formulations targeting the XFG variant for older adults and high-risk individuals.

Credit: Getty Images Increasing evidence shows that obstructive sleep apnea is more prevalent and severe in women than once thought. Obstructive sleep apnea (OSA) has been classically understood as a ...

HealthDay News — A Pennsylvania coroner has confirmed that measles killed one of two infants who died in the state last month, but federal health officials still are not counting either death in the ...

B-cell-depleting therapy linked to lower relapse incidence, greater T2 lesion volume reduction compared with oral platform therapies ...